149 related articles for article (PubMed ID: 19688977)
1. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.
Dimova I; Orsetti B; Negre V; Rouge C; Ursule L; Lasorsa L; Dimitrov R; Doganov N; Toncheva D; Theillet C
Tumori; 2009; 95(3):357-66. PubMed ID: 19688977
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.
Lassus H; Laitinen MP; Anttonen M; Heikinheimo M; Aaltonen LA; Ritvos O; Butzow R
Lab Invest; 2001 Apr; 81(4):517-26. PubMed ID: 11304571
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
[TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
[TBL] [Abstract][Full Text] [Related]
6. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
7. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
Tapper J; Bützow R; Wahlström T; Seppälä M; Knuutila S
Br J Cancer; 1997; 75(12):1782-7. PubMed ID: 9192982
[TBL] [Abstract][Full Text] [Related]
8. Genomic imbalances in ovarian borderline serous and mucinous tumors.
Hu J; Khanna V; Jones MM; Surti U
Cancer Genet Cytogenet; 2002 Nov; 139(1):18-23. PubMed ID: 12547152
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
[TBL] [Abstract][Full Text] [Related]
10. A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization.
Watanabe T; Imoto I; Kosugi Y; Ishiwata I; Inoue S; Takayama M; Sato A; Inazawa J
Gynecol Oncol; 2001 May; 81(2):172-7. PubMed ID: 11330945
[TBL] [Abstract][Full Text] [Related]
11. The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
Wojnarowicz PM; Oros KK; Quinn MC; Arcand SL; Gambaro K; Madore J; Birch AH; de Ladurantaye M; Rahimi K; Provencher DM; Mes-Masson AM; Greenwood CM; Tonin PN
PLoS One; 2012; 7(9):e45484. PubMed ID: 23029043
[TBL] [Abstract][Full Text] [Related]
12. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
[TBL] [Abstract][Full Text] [Related]
13. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization.
Sakakura C; Mori T; Sakabe T; Ariyama Y; Shinomiya T; Date K; Hagiwara A; Yamaguchi T; Takahashi T; Nakamura Y; Abe T; Inazawa J
Genes Chromosomes Cancer; 1999 Apr; 24(4):299-305. PubMed ID: 10092127
[TBL] [Abstract][Full Text] [Related]
14. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma.
Zweemer RP; Ryan A; Snijders AM; Hermsen MA; Meijer GA; Beller U; Menko FH; Jacobs IJ; Baak JP; Verheijen RH; Kenemans P; van Diest PJ
Lab Invest; 2001 Oct; 81(10):1363-70. PubMed ID: 11598149
[TBL] [Abstract][Full Text] [Related]
16. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
[TBL] [Abstract][Full Text] [Related]
18. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
[TBL] [Abstract][Full Text] [Related]
19. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.
Tagawa H; Karnan S; Suzuki R; Matsuo K; Zhang X; Ota A; Morishima Y; Nakamura S; Seto M
Oncogene; 2005 Feb; 24(8):1348-58. PubMed ID: 15608680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]